First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein a as predictors of pregnancy complications

British Journal of Obstetrics and Gynaecology

Volumn 107, Issue 10, 2000, Pages 1265-1270

  Ong, Charas Y T ^a   Liao, Adolfo W ^a   Spencer, Kevin ^b   Munim, Shama ^a   Nicolaides, Kypros H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAROLD WOOD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GONADOTROPIN BLOOD LEVEL; GROWTH REGULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREDICTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMAN; MIDDLE AGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; STAPHYLOCOCCAL PROTEIN A;

EID: 0033799683     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb11618.x     Document Type: Article

References (24)

1. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β human chorionic gonadotropin and pregnancy-associated plasma protein-A
2. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome
3. Beta-human chorionic gonadotrophin levels before and after the development of pre-eclampsia
4. Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension
5. Elevated second trimester human chorionic gonadotropin levels in association with poor pregnancy outcome
6. Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome
7. HCG and its subunits in first trimester Down Syndrome screening
8. Screening for Down's syndrome: Changes in marker levels and detection rates between first and second trimesters
9. Pregnancy-associated plasma protein A in the prediction of early pregnancy failure
10. Does ultrasound examination render biochemical tests obsolete in the prediction of early pregnancy failure?
11. Can pregnancy-associated plasma protein A (PAPP-A) predict the outcome of pregnancy in women with threatened abortion and confirmed fetal viability?
12. Low maternal serum pregnancy associated plasma protein A and fetal viability
13. Reduced circulating placental protein concentrations during the first trimester are associated with preterm labour and low birth weight
14. Human placental lactogen and pregnancy-associated plasma protein A in the first trimester and subsequent fetal growth restriction
15. The classification and definition of the hypertensive disorders of pregnancy
16. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks
17. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: Implications for screening for Down's syndrome
18. Serum levels of haman placental lactogen, pregnancy-associated plasma protein A and endometrial secretory protein PP14 in first trimester of diabetic pregnancy
19. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta hCG, pregnancy associated plasma protein A at 10-14 weeks of gestation
20. Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hOG, pregnancy associated plasma protein A at 10-14 weeks of gestation
21. Screening for triploidy by fetal nuchal translucency and maternal serum free β human chorionic gonadotropin, pregnancy associated plasma protein A at 10-14 weeks of gestation
22. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants
23. Maternal serum levels of free β human chorionic gonadotropin, pregnancy associated plasma protein A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery